New data from a research study has led BioNTech to announce that the Pfizer vaccine can be stored and transported at -25°C to-15°C (-13°F to 5°F), a warmer temperature than originally thought. This could allow more pharmacies to handle the vaccine without using an ultra-cold freezer. BioNTech is currently awaiting FDA approval for the storage requirement change. The study also showed that a single dose of the vaccine is more effective than originally thought as well, however, this does come with limitations and receiving the second dose is still highly recommended for proper immunization.

Johnson & Johnson submitted paperwork on Thursday, February 4th to the FDA requesting authorization of it’s single-dose COVID-19 vaccine. The FDA COVID-19 advisory committee will meet on Friday, February 26th to review the application. In a U.S. clinical trial, the Johnson & Johnson vaccine was shown to be 72% effective. The vaccine can be stored at refrigerated temperatures, rather than below freezing like the Moderna and Pfizer vaccines.

Starting on February 11th, the federal government will be shipping Covid-19 vaccine supplies directly to pharmacy doors. This is part of the initiative to increase vaccination rates in the United States, and will be accomplished in collaboration with national pharmacy partners. In addition to the chains, this will also include independent pharmacy networks such as CPESN USA and Good Neighbor Pharmacy. This direct shipment to pharmacies will reduce some barriers in distribution of the vaccine and hopefully help get the doses quickly into arms.

This article addresses several common objections to the COVID-19 vaccine or vaccinations in general. Suggested responses are written in a way that any patient or loved one can understand. Educate and put your patients at ease with this helpful conversation guide.